평생의학교육의 의사-제약회사 관계

박재현1, 정유석2,*
Jae-Hyun PARK1, Yoo-Seock CHEONG2,*
Author Information & Copyright
1경희대학교 의학전문대학원 의학교육학교실
2단국대학교 의과대학 의료윤리학교실
1Department of Medical Education, School of Medicine, Kyung Hee University
2Department of Medical Ethics, College of Medicine, Dankook University
*교신저자: 정유석. 단국대학교 의과대학 의료윤리학교실. 041-550-6385.

ⓒ Copyright 2011 The Korean Society for Medical Ethics. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: Aug 30, 2011; Accepted: Sep 16, 2011

Published Online: Sep 30, 2011


Physicians have both an ethical obligation and a right to participate in continuing medical education (CME) programs to constantly maintain and upgrade their knowledge and skills after the completion of their formal education. CME is the pharmaceutical industry’s most important marketing tool. CME is increasingly being funded by the pharmaceutical industry; currently the financial support from drug and device companies accounts for up to 60% of the costs of all accredited CME programs in the U.S. CME requirements for Korean physicians are somewhat lax at the present time, but industry sponsored CME is on the rise in Korea. With the increase in industry funded CME, there is cause for concern about potential conflicts of interest, scientific biases, and the educational quality of industry-funded CME. Physicians’ reliance on industry-funded CME has the potential to influence negatively their clinical decisions and to increase spending on prescription drugs. For these reasons, a growing number of medical institutions in the U.S. have limited or phased-out industry sponsorship of CME at their institutions. This article argues that in order to ensure the professional integrity of physicians and the process of learning in CME, physicians and pharmaceutical industries need more explicit codes of conduct and guidelines. Individual doctors should recognize the potential for the industry to influence their prescribing habits and follow the ethical principles of physician-industry relationships. Also, in order to better balance learning needs and patient concerns, physicians should have the information and skills required to make informed decisions in CME.

Keywords: 평생의학교육; 의사-제약 회사 상호관계; 윤리적 관계
Keywords: continuing medical education; physician-pharmaceutical industry interaction; ethical relationship

[특집 논문] 필수의료의 위기와 의학전문직업성

2023년 12월 호(12월 31일 발행)에서는 특집호를 계획하고 있으며, 특집논문(필수의료의 위기와 의학전문직업성)에 대한 논평을 받고 있습니다.

특집논문에 대한 논평을 작성하시고자 하는 선생님께서는 논평자의 학문적 지견과 관점을 담아 특집논문을 논평해 주시기 바랍니다.

*특집논문의 전체 본문은 아래의 링크에서 다운로드 가능합니다.

공지사항 바로가기

I don't want to open this window for a day.